Strattera has an FDA warning for increased risk of suicidal thoughts in It may help to increase the ability to pay attention, concentrate, stay focused, and stop fidgeting
Adderall and Strattera are medications prescribed to treat attention disorders, including attention-deficit/hyperactivity disorder (ADHD)
Atomoxetine (Strattera) is a selective norepinephrine reuptake inhibitor ( NRI )
Strattera (atomoxetine) is a prescription drug used to treat attention deficit hyperactivity disorder (ADHD)
It works by increasing the amount of norepinephrine in the central nervous system, a brain chemical
Common medications that may interact with Strattera include: albuterol amiodarone bupropion chlorpheniramine clomipramine anti-anxiety medications
Strattera (Generic Name: atomoxetine) is an alternative to the stimulant ADHD medications most commonly used to treat symptoms of attention deficit hyperactivity
ADHD is commonly treated with stimulant medications, which carry the potential for substance misuse
This is not a complete list of side effects and others may occur
Let’s take a look at nine Strattera side effects and ways to manage them
Children also experience it, but at a lower rate
It is recommended that heart rate and blood pressure be measured before treatment is started, after the dose is increased or decreased, STRATTERA is not approved for major depressive disorder
Amphetamine Sulfate
More common side effects in children and adolescents taking Strattera include: nausea
Can't find what you're looking for? Contact us for answers to your medical questions
Check with your doctor immediately if any of the following side effects occur: Less common
Atomoxetine is subsidised on the Pharmaceutical Benefits Scheme for people who
A recent review of clinical trial data in children and adults with ADHD showed mean increases in blood pressure and heart rate with In this article, we’ll focus on one of the most common non-stimulant medications –– Strattera (atomoxetine)
For some, this medication has proven to be effective
We're an inclusive, disability-oriented peer support group for people with ADHD with an emphasis on science-backed information
Discontinue interfering drugs for at least 5 half-lives before administration of either the dosimetry or an iobenguane dose
It was approved by the Food and Drug Administration (FDA) in 2002, and became the first non-stimulant medication to receive approval for ADHD